Systematic review: the hepatotoxicity of non-steroidal anti-inflammatory drugs.

作者: J. H. Rubenstein , L. Laine

DOI: 10.1111/J.1365-2036.2004.02092.X

关键词:

摘要: SUMMARY 1 Background: Non-steroidal anti-inflammatory drugs have been implicated in reports of liver injury. However, the precise risk non-steroidal for this rare complication is unknown. Aim: To review systematically published literature ofpopulation-basedepidemiological studies reportingthe incidence or comparative antiinflammatory injury resulting clinically significant events, defined as hospitalization death. Data extraction: Duplicate extraction methodological quality, design, source, population, years studied, particular definitions, patient counts and follow-up, adjustment confounders. Results: Seven articles met inclusion criteria. The current drug users compared with past ranged from 1.2 to 1.7, but none was statistically significant. 3.1 23.4/100 000 patient-years use nonsteroidal drugs, an excess 4.8‐8.6/100 exposure. There were zero deaths associated over 396 392 cumulative Conclusion: These findings allow possibility a small increase relevant hepatotoxicity use, do not document that such occurs.

参考文章(27)
Hershel Jick, Laura E. Derby, Susan S. Jick, Luis A. García Rodríguez, Alan D. Dean, Liver disease associated with diclofenac, naproxen, and piroxicam. Pharmacotherapy. ,vol. 12, pp. 207- 212 ,(1992) , 10.1002/J.1875-9114.1992.TB04511.X
Giorgio Merlani, Mark Fox, Hans-Peter Oehen, Gieri Cathomas, Eberhard L. Renner, Karin Fattinger, Markus Schneemann, Gerd A. Kullak-Ublick, Fatal hepatotoxicity secondary to nimesulide European Journal of Clinical Pharmacology. ,vol. 57, pp. 321- 326 ,(2001) , 10.1007/S002280100312
Jeffrey L Carson, Brian L Strom, Amy Duff, Anand Gupta, Kiron Das, None, Safety of Nonsteroidal Anti-inflammatory Drugs With Respect to Acute Liver Disease Archives of Internal Medicine. ,vol. 153, pp. 1331- 1336 ,(1993) , 10.1001/ARCHINTE.1993.00410110039007
Lee L. Lanza, Alexander M. Walker, Edward A. Bortnichak, Douglas O. Gause, Nancy A. Dreyer, Incidence of symptomatic liver function abnormalities in a cohort of NSAID users Pharmacoepidemiology and Drug Safety. ,vol. 4, pp. 231- 237 ,(1995) , 10.1002/PDS.2630040406
Catherine Sgro, François Clinard, Kader Ouazir, Henry Chanay, Christian Allard, Christian Guilleminet, Claude Lenoir, Alain Lemoine, Patrick Hillon, Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology. ,vol. 36, pp. 451- 455 ,(2002) , 10.1053/JHEP.2002.34857
P Trechot, P Gillet, G Gay, B Hanesse, P Netter, A Castot, D Larrey, Incidence of hepatitis induced by non-steroidal anti-inflammatory drugs (NSAID) Annals of the Rheumatic Diseases. ,vol. 55, pp. 936- 936 ,(1996) , 10.1136/ARD.55.12.936
Mei-Sheng Duh, Alexander M. Walker, Kenneth H. Kronlund, Descriptive epidemiology of acute liver enzyme abnormalities in the general population of central Massachusetts Pharmacoepidemiology and Drug Safety. ,vol. 8, pp. 275- 283 ,(1999) , 10.1002/(SICI)1099-1557(199907)8:4<275::AID-PDS427>3.0.CO;2-D
Russell P. Harris, Mark Helfand, Steven H. Woolf, Kathleen N. Lohr, Cynthia D. Mulrow, Steven M. Teutsch, David Atkins, Current methods of the US Preventive Services Task Force: a review of the process. American Journal of Preventive Medicine. ,vol. 20, pp. 21- 35 ,(2001) , 10.1016/S0749-3797(01)00261-6